Figure 9From: ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedsideComputed tomography scan of tumor response and cavitation of lesions in a patient with metastatic lung carcinoma showing cavitation after 2 treatment periods. (with permission from Journal of Clinical Oncology) [64].Back to article page